LOS ANGELES--(BUSINESS WIRE)--Grant Life Sciences (‘Grant’) Inc. (OTC BB: GLIF) announced today that it has received a cash infusion of $400,000. The company intends to use this cash to fill outstanding orders for its products and continue validating its in-licensed diagnostic opportunities.
